LB
63
25
GT
46
-3
AIG
56
3
BAC
36
-3
ADM
31
-2
IRM
73
5
V
62
6
CLX
66
3
APA
30
5
HST
45
-12
BWA
48
3
TJX
48
-2
NWL
41
6
AIZ
73
4
PFE
28
-2
HBI
55
-7
DD
56
3
LH
50
2
SRE
56
2
USB
53
9
LB
63
25
GT
46
-3
AIG
56
3
BAC
36
-3
ADM
31
-2
IRM
73
5
V
62
6
CLX
66
3
APA
30
5
HST
45
-12
BWA
48
3
TJX
48
-2
NWL
41
6
AIZ
73
4
PFE
28
-2
HBI
55
-7
DD
56
3
LH
50
2
SRE
56
2
USB
53
9
Financhill
Back

First Trust Cnsmr Staples AlphaDEX® ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
46

FXG
First Trust Cnsmr Staples AlphaDEX® ETF

Last Price:
68.07
Seasonality Move:
0.77%
Sell
22

APLS
Apellis Pharmaceuticals

Last Price:
32.71
Seasonality Move:
18.8%
Sell
46
First Trust Cnsmr Staples AlphaDEX® ETF (FXG) is a Sell

Is First Trust Cnsmr Staples AlphaDEX® ETF a Buy, Sell or Hold?

  • The current First Trust Cnsmr Staples AlphaDEX® ETF [FXG] share price is $68.08. The Score for FXG is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • FXG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.72. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FXG Stock Price Chart

What is First Trust Cnsmr Staples AlphaDEX® ETF's stock price today?

  • The First Trust Cnsmr Staples AlphaDEX® ETF share price today is $68.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FXG is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

FXG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.28 Buy
Relative Strength Index (14 RSI): 54.87 Buy
Chaikin Money Flow: 4050 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.49 - 68.47) Buy
Bollinger Bands (100): (65.01 - 67.73) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.09 Sell
Relative Strength Index (14 RSI): 34.53 Sell
Chaikin Money Flow: 2311416 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.9 - 40.1) Sell
Bollinger Bands (100): (36.41 - 42.27) Sell

FXG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.99 Buy
20-day SMA: 68.11 Sell
50-day SMA: 66.95 Buy
200-day SMA: 65.42 Buy
8-day EMA: 68.02 Buy
20-day EMA: 67.86 Buy
50-day EMA: 67.18 Buy
200-day EMA: 65.49 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.48 Sell
20-day SMA: 37.67 Sell
50-day SMA: 37.75 Sell
200-day SMA: 49.84 Sell
8-day EMA: 35.24 Sell
20-day EMA: 36.78 Sell
50-day EMA: 38.03 Sell
200-day EMA: 45.57 Sell

First Trust Cnsmr Staples AlphaDEX® ETF Earnings Growth & FXG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.32 per share.

First Trust Cnsmr Staples AlphaDEX® ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):